具核梭杆菌靶向lncRNA ENO1-IT1促进结直肠癌糖代谢与致癌
该研究在33例结直肠癌患者中发现具核梭杆菌丰度与高糖代谢相关,机制上该菌通过SP1上调lncRNA ENO1-IT1转录,ENO1-IT1引导KAT7组蛋白乙酰转移酶修饰靶基因(包括ENO1),改变结直肠癌细胞生物学功能;靶向ENO1通路可能对具核梭杆菌升高的结直肠癌患者有治疗意义。
要点
- 具核梭杆菌丰度与结直肠癌患者高糖代谢相关
- 该菌经SP1上调lncRNA ENO1-IT1转录促进糖代谢与致癌
- 靶向ENO1通路或对具核梭杆菌升高的结直肠癌有意义
核心结论
- 具核梭杆菌与糖代谢在机制、生物学和临床上与结直肠癌相关
- 靶向ENO1通路可能对具核梭杆菌升高的结直肠癌患者有治疗意义
研究设计与样本
- 对33例结直肠癌患者行18F-FDG PET/CT扫描数据与微生物PCR分析
- 建立多种结直肠癌模型,采用代谢分析和Seahorse assay评估lncRNA ENO1-IT1作用
- 采用RNA免疫沉淀和染色质免疫沉淀测序鉴定lncRNA ENO1-IT1的潜在靶点
主要发现
- 在33例结直肠癌患者中具核梭杆菌丰度与高糖代谢相关
- 具核梭杆菌通过增加结直肠癌细胞糖代谢支持致癌
- 具核梭杆菌通过上调转录因子SP1与lncRNA ENO1-IT1启动子区结合效率激活其转录
- 升高的ENO1-IT1作为KAT7组蛋白乙酰转移酶的引导模块,指定靶基因(包括ENO1)的组蛋白修饰模式
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Microbiota disorder promotes chronic inflammation and carcinogenesis. High glycolysis is associated with poor prognosis in patients with colorectal cancer (CRC). However, the potential correlation between the gut microbiota and glucose metabolism is unknown in CRC. DESIGN: 18F-FDG (18F-fluorodeoxyglucose) PET (positron emission tomography)/CT image scanning data and microbiota PCR analysis were performed to measure the correlation between metabolic alterations and microbiota disorder in 33 patients with CRC. Multiple colorectal cancer models, metabolic analysis and Seahorse assay were established to assess the role of long non-coding RNA (lncRNA) enolase1-intronic transcript 1 (ENO1-IT1) in Fusobacterium (F.) nucleatum-induced glucose metabolism and colorectal carcinogenesis. RNA immunoprecipitation and chromatin immunoprecipitation sequencing were conducted to identify potential targets of lncRNA ENO1-IT1. RESULTS: We have found F. nucleatum abundance correlated with high glucose metabolism in patients with CRC. Furthermore, F. nucleatum supported carcinogenesis via increasing CRC cell glucose metabolism. Mechanistically, F. nucleatum activated lncRNA ENO1-IT1 transcription via upregulating the binding efficiency of transcription factor SP1 to the promoter region of lncRNA ENO1-IT1. Elevated ENO1-IT behaved as a guider modular for KAT7 histone acetyltransferase, specifying the histone modification pattern on its target genes, including ENO1, and consequently altering CRC biological function. CONCLUSION: F. nucleatum and glucose metabolism are mechanistically, biologically and clinically connected to CRC. Targeting ENO1 pathway may be meaningful in treating patients with CRC with elevated F. nucleatum.
引用
- Hong J, Guo F, Lu SY, et al. F. nucleatum targets lncRNA ENO1-IT1 to promote glycolysis and oncogenesis in colorectal cancer. Gut. 2020. PMID: 33318144. doi:10.1136/gutjnl-2020-322780
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。